C L A R I D E N 18-19 October 2012 Knowledge for the world business leaders Shangri-La Hotel, Singapore Creating Winning Strategies for Pharmaceutical Launch Success: An Integrated Approach from Strategic Planning to Commercialization & Launch Success Faculty Director Hany Salama Renowned Thought Leader in Pharmaceutical Industry - Key Council Member and Advisor at Gerson Lehrman Group where he advises global pharmaceutical and biotech companies on best practices in value chain transformation, commercialization and successful product launches Advised some of the most renowned companies including McKinsey, Goldman Sachs, Morgan Stanley, UBS, KPMG, Boston Consulting Group, Ernst & Young and many other FORTUNE 500 companies Adjunct Professor at Rutgers University where he holds an Advisory Board Seat at the Graduate Business School Hany Salama (ME, MBA, CPM, CPSM) is a senior management executive at NeoStrata and a highly acclaimed Professor at Rutgers University Graduate Business School. As a renowned thought leader in global pharmaceutical and biotechnology, Hany has advised over 600 pharma, biotech and other companies over the world. He has advised some of the most renowned companies including McKinsey, Goldman Sachs, UBS, KPMG, Boston Consulting Group, Ernst & Young and many other FORTUNE 500 companies. As a Key Council Member and Advisor at Gerson Lehrman Group, Hany is a frequently soughtafter consultant where he has advised global private equity firms, venture capitalists, and operating companies on specialty pharmaceutical and biotechnology topics, including strategies for successful product launches, commercialization, value chain transformation and global pharma strategies to keep their organizations competitive. He is a graduate of Illinois Institute of Technology where he earned a Masters in Engineering.
Creating Winning Strategies for Pharmaceutical Launch Success: An Integrated Approach from Strategic Planning to Commercialization & Launch Success F A C U L T Y D I R E C T O R Mr Hany Salama Renowned Thought Leader in Pharmaceutical Industry - Key Council Member and Advisor at Gerson Lehrman Group where he advises global pharmaceutical and biotech companies on best practices in value chain transformation, commercialization and successful product launches Advised some of the most renowned companies including McKinsey, Goldman Sachs, Morgan Stanley, UBS, KPMG, Boston Consulting Group, Ernst & Young and many other FORTUNE 500 companies Adjunct Professor at Rutgers University where he holds an Advisory Board Seat at the Graduate Business School Hany Salama (ME, MBA, CPM, CPSM) is a senior management executive at NeoStrata and a highly acclaimed Professor at Rutgers University Graduate Business School. As a renowned thought leader in global pharmaceutical and biotechnology, Hany has advised over 600 pharma, biotech and other companies over the world. He has advised some of the most renowned companies including McKinsey, Goldman Sachs, UBS, KPMG, Boston Consulting Group, Ernst & Young and many other FORTUNE 500 companies. As a Key Council Member and Advisor at Gerson Lehrman Group, Hany is a frequently sought-after consultant where he has advised global private equity firms, venture capitalists, and operating companies on specialty pharmaceutical and biotechnology topics, including strategies for successful product launches, commercialization, value chain transformation and global pharma strategies to keep their organizations competitive. He is a graduate of Illinois Institute of Technology where he earned a Masters in Engineering. EXECUTIVE SUMMARY Program: Dates: Location: Creating Winning Strategies for Pharmaceutical Launch Success: An Integrated Approach from Strategic Planning to Commercialization & Launch Success 18-19 October 2012 (2 days) Shangri-La Hotel, Singapore Early Bird 1 (Register & pay by 31 Aug 2012): S$3,350 Early Bird 2 (Register & pay by 20 Sep 2012): S$3,550 Regular Tuition Fee: S$3,650 For limited period only: Registration for 2 participants, 10% on 2nd participant. For limited time only by 31 Aug, registration for 3 participants, the 4th participant will receive a complimentary seat (one discount scheme will apply). Note: GST is applicable only to participants from Singapore registered companies. Program Essence: This comprehensive 2-day Creating Winning Strategies for Pharmaceutical Launch Success: An Integrated Approach from Strategic Planning to Commercialization & Launch Success is designed for senior and middle executives to provide you with the business concepts and practical tools to develop an integrated strategy to create successful product launches. In this pharmaceutical excellence program, you will discover the best practices adopted by leading firms on developing world class launch strategy and how you can implement it for your own organization. You will gain a deeper understanding of drug development through commercialization lifecycle, learn the mechanism behind launch plan decision making, integrated project management, manufacturing and production strategy, supply chain strategy, financial analysis of launch, distribution network design, product valuation and life cycle management. You will also learn the marketing success stories behind some of the world s top selling drugs where you will learn the marketing profiles, tactics and strategies that made these products into blockbusters. This program s active-learning approach blends interactive Stanford Business School and Kellogg School of Management s case studies, real world simulations and group discussions with hands-on experiences that put the principles into practice. Taught by a renowned thought leader in pharmaceutical industry, you will learn to design and execute an integrated strategy at the end of the program to successfully launch your products and compete in this global landscape. 1
PROGRAM OVERVIEW What are the winning strategies and tactics that create successful pharmaceutical product launches? It has been estimated that to successfully bring a new drug to market, organizations could take up to 12 to 15 years and spend up to US$1 billion for commercialization success. Pharmaceutical companies have only one chance to make a successful impact with their product. Pharmaceutical executives therefore need to have a winning strategy right from the beginning to ensure successful drug launches. Creating Winning Strategies for Pharmaceutical Launch Success: An Integrated Approach from Strategic Planning to Commercialization & Launch Success shows you how you can develop an integrated strategy to create successful product launches. You will discover the best practices adopted by leading firms on developing world class launch strategy and how you can implement it for your own organization. You will gain a deeper understanding of drug development through commercialization lifecycle, learn the mechanism behind launch plan decision making, integrated project management, manufacturing and production strategy, supply chain strategy, financial analysis of launch, distribution network design, product valuation and life cycle management. You will also learn the marketing success stories behind some of the world s top selling drugs where you will learn the marketing profiles, tactics and strategies that made these products into blockbusters. This program s active-learning approach blends interactive Stanford Business School and Kellogg School of Management s case studies, real world simulations and group discussions with hands-on experiences that put the principles into practice. The faculty will challenge you to examine your own organization s strategies and understand why many of the current strategies won t get the results you need. This executive program will also review challenges for the future and how leading pharmaceutical companies strategies will need to fundamentally change to adapt to increased global competition, new regulations and shifting value chain. You will gain knowledge on different aspects of value chain in pharmaceutical industry, drug discovery process, clinical trial development, regulatory filings, manufacturing and product lifecycle management. At the end of the two-day program, you will learn to design and execute an integrated strategy for successful product launches and strategies for keeping your organization competitive. KEY TAKEAWAYS In this intensive two-day executive program, you will learn to: Create steps to execute a world class product launch and commercialization strategy, including Integrated Project Management Production and Supply Chain Strategy Financial Analysis of Product Launches Distribution Network Design Product Valuation and Lifecycle Management Understand the marketing success stories behind some of the world s top selling drugs. Learn the marketing profiles, tactics and strategies that made these products into blockbusters Understand best management practices employed during key launch activities Gain a clear understanding on the future of pharmaceutical industry, regulatory outlook, competitive landscape and transforming value chains Gain a clear understanding of different segments of pharmaceuticals value chain as well as complexity and strategies for keeping your organization competitive P A R T I C I P A N T M I X This executive program is designed for executives in the pharmaceutical and biotechnology industry including: Middle and Senior-level executives who have responsibilities in research & development, clinical operations, strategic planning, medical affairs, project management, manufacturing, supply chain, finance, marketing, business development and other related departments Pharmaceutical and Biotechnology executives seeking to enrich their knowledge with cutting edge pharmaceutical strategies for success. Pharmaceutical business executives seeking to enrich their knowledge of the pharmaceutical strategic planning and launch plans while gaining an understanding of the future of the industry and how pharmaceutical organizations will compete 2
TWO DAY AGENDA DAY 1 GLOBAL INTEGRATED PRODUCT LAUNCH LANDSCAPE MORNING Strategic Planning and Launch Fundamentals Overview of the key activities involved with pharmaceutical product launches Key stakeholder roles and responsibilities and their associated decision points Developing an integrated world-class launch strategy: commercialization, licensing, joint ventures, etc. AFTERNOON Step Approach to Execute a World-Class Plan Global and regional launch strategies Strategies on how to time the activities associated with launching a product from development to commercialization The dos and don ts of partnerships Key new drug success factors: promotion and positioning Stanford Graduate School of Business Abbott Laboratories and Humira: Launching a Blockbuster Drug DAY 2 OPERATIONAL EFFECTIVENESS THROUGH WORLD-CLASS LAUNCH PLANS MORNING Factoring Product Innovation and Development in Launch Strategies Drug development pipelines and the impact on the launch strategies Research and development process: reaching the market sooner with a robust development approach Regulatory outlook and the impact on the innovation and launch plans Kellogg School of Management AstraZeneca, Prilosec, and Nexium: Strategic Challenges in Launching a Second Generation Drug AFTERNOON Pharmaceutical Industry Challenges The Future of the Industry Understanding the challenges and how pharmaceutical companies will stay competitive in the future Identify and address the lack of global and local functional alignment on strategy, execution and definition of success Addressing the quality and timeliness issues from the sheer number of activities and interdependencies delayed mobilization, lack of resources and inconsistent execution Addressing the issues of limited visibility into launch preparation across functions and regions Course recap and conclusion Awarding certificates It has been estimated that to successfully bring a new drug to market, organizations could take up to 12 to 15 years and spend up to US$1 billion for commercialization success. Pharmaceutical companies have only one chance to make a successful impact with their product. Registration begins at 8.30 am on Day 1. Program starts at 9 am on all days, and ends at 5pm. There will be breaks for midmorning refreshment, lunch and mid-afternoon refreshment. Programs, dates and locations are subject to change. 3
CREATING WINNING STRATEGIES FOR PHARMACEUTICAL LAUNCH SUCCESS: AN INTEGRATED APPROACH FROM STRATEGIC PLANNING TO COMMERCIALIZATION & LAUNCH SUCCESS 18-19 October 2012 Shangri-La Hotel, Singapore REGISTRATION PAGE C L A R I D E N Knowledge for the world business leaders Booking Contact (Approving Manager) Mr/Mrs/Ms: Job Title: Department: Telephone: Fax: Email: Organisation: Address: Postal Code: I would like to receive more information on hotel accommodation using corporate rate. Please register the following participant(s) for this Program: 1st Participant Name (Mr/Mrs/Ms): 2nd Participant Name (Mr/Mrs/Ms): 3rd Participant Name (Mr/Mrs/Ms): 4th Participant Name (Mr/Mrs/Ms): PROGRAM FEES 1 ST EARLY BIRD FEE: S$3,350 (Registration and payment must be received by 31 August 2012) 2 ND EARLY BIRD FEE: S$3,550 (Registration and payment must be received by 20 September 2012) REGULAR FEE: S$3,650 GROUP DISCOUNT: For 2 registrations from the same company and billing source, the 2nd participant enjoys a 10% discount. For registrations of 3 from the same company and billing source, the 4th participant receives a complimentary seat. One discount scheme applies per company. Note: GST is applicable only to participants from Singapore registered companies. Important Notice: Payments are required with registration and must be received prior to the Course to guarantee your place. PAYMENT METHODS BY CHEQUE / BANK DRAFT: Made payable to Pte Ltd and mail to: 3 International Business Park, #04-31, Nordic European Centre, Singapore 609927. BY TELEGRAPHIC TRANSFER TO: Bank Name: DBS BANK Bank Branch Code: 027 Bank Address: 6 Shenton Way, DBS Building, Singapore 068809 Bank Account No: 027-903583-8 Bank Account name: Pte Ltd Bank SWIFT Code: DBSSSGSG Please note that all bank charges are to be borne by participants. Please ensure receives the full invoiced amount. Note: Please include invoice number on all payment types and your company s name in your payment instructions for our reference. CREDIT CARD: To make payment by credit card, please call our client services hotline at +65 6899 5030. 4 WAYS TO REGISTER Email: admissions@claridenglobal.com Fax: +65 6567 4328 Call: +65 6899 5030 Website: www.claridenglobal.com DATE AND LOCATION This executive program will be held at: Shangri-La Hotel, Singaporee 18-19 October 2012 22 Orange Grove Road, Singapore 258350 Tel : +65 6737 3644 Fax : +65 6737 3257 Website : www.shangri-la.com/en/property/singapore/shangrila The fee for this two-day executive program includes all written materials, lunch and refreshments. HOW TO REGISTER AND PAY An invoice and registration confirmation will be sent within 7 days, please contact us if you have not heard from us within 7 days. Payment can be made by credit card, by bank transfer or by cheque made payable to Pte Ltd. ALL PAYMENTS MUST BE RECEIVED IN ADVANCE OF THE EVENT. ACCOMMODATION Accommodation is not included in the program fee but you will be entitled to use our corporate rate for your accommodation. Information will be sent along with your registration confirmation. SPONSORSHIP INTERESTED IN PROMOTING YOUR ORGANIZATION TO OUR PARTICIPANTS For more information on sponsorship, tabletop displays & insert opportunities, please contact us at 6899 5030. CANCELLATIONS AND SUBSITUTIONS Once we have received your booking, the place(s) are confirmed. No refunds will be made for any cancellations, however, program credits of equivalent value only applicable for events will be provided. Credits can only be redeemed for 1 program and is valid for only one (1) year from date of issue. Substitution with a qualified candidate is allowed by providing at least 5 working days of advance notice to. One time substitution is allowed with no charges. Subsequent substitutions will be charged 10% admin fee. ALL CANCELLATIONS MUST BE RECEIVED IN WRITTEN FORM PLEASE NOTE: Pte Ltd reserves the right to change the content and timing of the programme, the speakers and the date and venue due to reasons beyond their control. If in the unlikely event that the course is cancelled, Clariden Global Pte Ltd will refund the full amount and disclaim any further liability. ENQUIRIES: If you have any queries about registration or payment please do not hesitate to contact our client services department on +65 6899 5030. PRIVATE DISCLOSURE STATEMENT: Any information provided by you in relation to this event is being collected by Pte Ltd and will be held in the strictest confidence. It will be added to our database for the primary purpose of providing you with information about future events and services. Visit us at www.claridenglobal.com for upcoming events FOR OFFICIAL USE FEE RECEIVED L9012/BY/JT